CSF2 and COVID-19: While early studies demonstrated elevated GM-CSF levels in both ICU and non-ICU treated COVID-19 patients (1), we now demonstrate a positive association with disease severity and outcome, in agreement with reports of elevated frequencies of GM-CSF+ Th1 cells in patients with COVID-19 requiring ICU treatment (61).